Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02557321
Title PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Provectus Pharmaceuticals
Indications

melanoma

Therapies

PV-10

Pembrolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.